VIVUS Reports Second Quarter 2017 Financial Results
CAMPBELL, CA--(Marketwired - August 03, 2017) - VIVUS, Inc. (NASDAQ: VVUS) (the "Company"), a biopharmaceutical company committed to the development and commercialization of innovative therapies focusing on treatments for patients with serious …